Nuvectis Pharma, Inc. Common Stock (NVCT) is a publicly traded Healthcare sector company. As of July 6, 2026, NVCT trades at $20.32 with a market cap of $616.95M and a P/E ratio of -14.83. NVCT moved +0.00% today. Year to date, NVCT is +165.18%; over the trailing twelve months it is +160.24%. Its 52-week range spans $4.44 to $29.28. Analyst consensus is strong buy with an average price target of $27.75. Rallies surfaces NVCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Nuvectis Pharma, Inc. Common Stock (NVCT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NVCT moved +0.00% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $20.32 |
| Market Cap | $616.95M |
| P/E Ratio | -14.83 |
| EPS | $-1.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $29.28 |
| 52-Week Low | $4.44 |
| Volume | 980 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.44M |
| Gross Margin | 0.00% |
4 analysts cover NVCT: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $27.75.